Showing results (451-460 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 27, 2018
Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple SclerosisCarlos Navas, Carlos A Torres-Duque, Joe Munoz-Ceron, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 3, 2018
Risk factors for fingolimod-induced lymphopenia in multiple sclerosisRyohei Ohtani, Masahiro Mori, Tomohiko Uchida, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2018
A randomized study to evaluate the effect of exercise on fatigue in people with relapsing-remitting multiple sclerosis treated with fingolimodM Mäurer, K Schuh, S Seibert, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 5, 2017
Testing patient-reported outcome measurement equivalence in multinational clinical trials: An exemplar using the 12-item Multiple Sclerosis Walking ScaleHussein Dib, Yusuf Tamam, Murat Terzi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 6, 2017
Cognitive and neuropsychiatric disorders among MS patients from Latin AmericaSandra Vanotti, Fernando J Caceres
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 6, 2017
Application of the McDonald criteria in Latin AmericaLiliana Patrucco
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 22, 2018
A real-world comparison of relapse rates, healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugsJames D Bowen, Chris M Kozma, Megan M Grosso, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 10, 2019
A case of autoimmune myositis after treatment with alemtuzumab for multiple sclerosisPatrick Aouad, Con Yiannikas, Suran L Fernando, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 6, 2021
Confirmed disability progression provides limited predictive information regarding future disease progression in multiple sclerosisBrian C Healy, Bonnie I Glanz, Elyse Swallow, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 23, 2020
Corrigendum
Pageof 61